Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
ACS Medicinal Chemistry Letters
|
June 6, 2014
[3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase β Inhibitors
Hongyi Yu, Michael L Moore, Karl Erhard, et al.
Nature Chemical Biology
|
August 4, 2014
A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site
Mary Ann Hardwicke, Alan R Rendina, Shawn P Williams, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2012
Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent β isoform selective phosphatidylinositol 3-kinase inhibitors
Robert M Sanchez, Karl Erhard, Mary Ann Hardwicke, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2008
Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas
Jian Jin, Yonghui Wang, Dongchuan Shi, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists
Jian Jin, Dashyant Dhanak, Steven D Knight, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 27, 2009
M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines
Brian Budzik, Yonghui Wang, Dongchuan Shi, et al.
Journal of Medicinal Chemistry
|
September 19, 2008
Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists
Jian Jin, Brian Budzik, Yonghui Wang, et al.
Journal of Medicinal Chemistry
|
August 6, 2008
Discovery of novel and long acting muscarinic acetylcholine receptor antagonists
Jian Jin, Yonghui Wang, Dongchuan Shi, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2007
Oxazolidinones as novel human CCR8 antagonists
Jian Jin, Yonghui Wang, Feng Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 9, 2008
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors
Krista B Goodman, Michael J Bury, Mui Cheung, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
ACS Medicinal Chemistry Letters
|
June 6, 2014
[3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase β Inhibitors
Hongyi Yu, Michael L Moore, Karl Erhard, et al.
Nature Chemical Biology
|
August 4, 2014
A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site
Mary Ann Hardwicke, Alan R Rendina, Shawn P Williams, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2012
Synthesis and structure-activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent β isoform selective phosphatidylinositol 3-kinase inhibitors
Robert M Sanchez, Karl Erhard, Mary Ann Hardwicke, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2008
Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas
Jian Jin, Yonghui Wang, Dongchuan Shi, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists
Jian Jin, Dashyant Dhanak, Steven D Knight, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 27, 2009
M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines
Brian Budzik, Yonghui Wang, Dongchuan Shi, et al.
Journal of Medicinal Chemistry
|
September 19, 2008
Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists
Jian Jin, Brian Budzik, Yonghui Wang, et al.
Journal of Medicinal Chemistry
|
August 6, 2008
Discovery of novel and long acting muscarinic acetylcholine receptor antagonists
Jian Jin, Yonghui Wang, Dongchuan Shi, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2007
Oxazolidinones as novel human CCR8 antagonists
Jian Jin, Yonghui Wang, Feng Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 9, 2008
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors
Krista B Goodman, Michael J Bury, Mui Cheung, et al.
Page
of 3